Celula, Inc., a San Diego, CA-based diagnostic testing company, closed a $10m senior secured term loan.
Oxford Finance provided the financing.
The company intends to use the funds to continue to develop and expand the commercialization of its products in the U.S. and China.
Led by Dr. Drew Senyei, chairman and chief executive officer, Celula is a diagnostic testing services company focused on improving the accuracy of diagnosing major diseases via an “Integrated Diagnostic Accuracy” platform (IDA) that combines algorithmically proprietary technologies and non-proprietary technologies- Its initial products focus on improving the diagnostic accuracy of major women’s diseases, specifically in gynecologic cancers and non-invasive prenatal diagnosis.
The company has an established infrastructure in both the U.S. and China.